Zobrazeno 1 - 10
of 37
pro vyhledávání: '"L. Khimion"'
Autor:
L. Khimion, L. Timoshchuk
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 3(55) (2017)
The article discusses in detail the problem of the medico-social significance of early kidney damage in essential hypertension (EH) (according to the literature review and own research). Aim. To determine the prevalence of subclinical renal damage
Externí odkaz:
https://doaj.org/article/838d4637b5f049af83c5fd1be1141f76
Autor:
L. Khimion, I. Klymas
Publikováno v:
Health of Society. 2:41-47
В статті висвітлені основні рекомендації та поради щодо виявлення, оцінки та ведення жертви насильства в сім’ї в практиці сімейного лі
Publikováno v:
Health of Society. 7:53-68
Autor:
L. Khimion, I. Klymas
Publikováno v:
Health of Society. 5:66-68
The article presents the polymorbidity spectrum in rheumatoid arthritis and lupus erythematosus patients based on own research and discusses the role of family physician in these patients care.
Autor:
Svitlana Danylyuk, Tetiana Sytyuk, L. Khimion, Nataliia Kicha, Oleksandr Burianov, Oksana Yashchenko
Publikováno v:
Family Medicine. :8-13
The evidence base for use of different rehabilitation programs is discussed in the article. The most effective approaches to the rehabilitation organization and patients education are presented together with the different types of physical rehabilita
Autor:
Alina V Boiko, L. Khimion
Publikováno v:
Wiadomości Lekarskie. 73:914-919
Objective The aim: To determine the features of atherosclerotic process, cardiovascular risk in patients with PsA. Patients and methods Materials and methods: The study included 42 patients with PsA who did not have atherosclerotic CVD, diabetes, chr
Publikováno v:
Health of Society. 5:51-52
The data about changes in lipid profile in rheumatoid arthritis patients with autoimmune thyroiditis is given in the article.
Autor:
L. Khimion, H. Havryliuk
Publikováno v:
Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini. 2019:91-94
Autor:
L. Khimion, H. Havryliuk
Publikováno v:
Journal of Clinical Orthopaedics and Trauma. 10:42-45
Publikováno v:
Annals of the Rheumatic Diseases. 81:1652.3-1652
Backgroundthe number of patients with progressive chronic kidney disease (CKD) and the costs of their treatment is constantly increasing. Possibly, control of serum uric acid (sUA) levels with urate lowering therapy (ULT) drugs can slow the progressi